File Download
  Patent History
  • Application
    PC T/CN2010001963 2010-12-06
  • Publication
    WO 2011066721 2011-06-09
Supplementary

published patent: ANTI-IGF-IR ANTIBODIES AND USES THEREOF

TitleANTI-IGF-IR ANTIBODIES AND USES THEREOF
Priority Date2009-12-04 US 12/266681P
Inventors
Issue Date2011
Citation
WO Published patent application WO 2011066721. World Intellectual Property Organization (WIPO), PatentScope, 2011 How to Cite?
AbstractThe subject invention provides antibodies, or binding fragments thereof, that specifically bind to human IGF-IR. Also provided are nucleic acid molecules encoding the antibodies and binding fragments of the subject invention and vectors and host cells containing these nucleic acid molecules. The disclosure also provides methods of inhibiting cancer cell growth and metastasis in a mammal using the antibodies described herein, as well as compositions containing the antibodies, nucleic acid molecules encoding the antibodies, and host cells and vectors comprising the nucleic acid molecules. The disclosure also features the use of the polypeptides to detect the presence of IGF-IR in a mammal, and epitopes that can be used as cancer vaccine immunogens.
Persistent Identifierhttp://hdl.handle.net/10722/177152

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:39:13Z-
dc.date.available2012-11-30T08:39:13Z-
dc.date.issued2011-
dc.identifier.citationWO Published patent application WO 2011066721. World Intellectual Property Organization (WIPO), PatentScope, 2011en_HK
dc.identifier.urihttp://hdl.handle.net/10722/177152-
dc.description.abstractThe subject invention provides antibodies, or binding fragments thereof, that specifically bind to human IGF-IR. Also provided are nucleic acid molecules encoding the antibodies and binding fragments of the subject invention and vectors and host cells containing these nucleic acid molecules. The disclosure also provides methods of inhibiting cancer cell growth and metastasis in a mammal using the antibodies described herein, as well as compositions containing the antibodies, nucleic acid molecules encoding the antibodies, and host cells and vectors comprising the nucleic acid molecules. The disclosure also features the use of the polypeptides to detect the presence of IGF-IR in a mammal, and epitopes that can be used as cancer vaccine immunogens.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleANTI-IGF-IR ANTIBODIES AND USES THEREOFen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorZhang, Men_HK
patents.identifier.applicationPC T/CN2010001963en_HK
patents.description.assigneeUNIV HONG KONG [CN]; ZHANG MEIYUN [CN]en_HK
patents.description.countryWorld Intellectual Property Organization (WIPO)en_HK
patents.date.publication2011-06-09en_HK
patents.identifier.hkutechidAIDS-2009-00339-3-
patents.date.application2010-12-06en_HK
patents.date.priority2009-12-04 US 12/266681Pen_HK
patents.description.ccWOen_HK
patents.identifier.publicationWO 2011066721en_HK
patents.relation.familyEP 2507263 (A1) 2012-10-10en_HK
patents.relation.familyUS 2011135663 (A1) 2011-06-09en_HK
patents.relation.familyWO 2011066721 (A1) 2011-06-09en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats